⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BDTX News
Black Diamond Therapeutics, Inc. Common Stock
Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update
globenewswire.com
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
BDTX
Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
BDTX